Help us shape the future of the Legislature website!

We are redesigning our website and want your feedback. We are looking for volunteers to participate in research, and some opportunities may be paid.    Sign up to participate here!
Bill Information > SB 6302
Search for another bill or initiative:
SB 6302 - 2007-08
Establishing standards for prescription drug marketing and disclosure.
Revised for 2nd Substitute: Reporting of gifts, fees, or payments by pharmaceutical marketers.
Sponsors: Kohl-Welles, Keiser, Fairley, Kline, Franklin, Regala
Bill History

2008 REGULAR SESSION

Jan 11
Prefiled for introduction.
Jan 14
First reading, referred to Health & Long-Term Care. (View Original Bill)
Jan 17
Public hearing in the Senate Committee on Health & Long-Term Care at 10:00 AM. (Committee Materials)
Jan 24
Executive action taken in the Senate Committee on Health & Long-Term Care at 10:00 AM. (Committee Materials)
Jan 25
HEA - Majority; 1st substitute bill be substituted, do pass. (View 1st Substitute) (Majority Report)
And refer to Ways & Means.
Minority; do not pass. (Minority Report)
Referred to Ways & Means.
Feb 11
Public hearing in the Senate Committee on Ways & Means at 1:30 PM. (Committee Materials)
Feb 12
Executive action taken in the Senate Committee on Ways & Means at 1:30 PM. (Committee Materials)
WM - Majority; 2nd substitute bill be substituted, do pass. (View 2nd Substitute) (Majority Report)
Minority; without recommendation. (Minority Report)
Passed to Rules Committee for second reading.
Feb 14
Placed on second reading by Rules Committee.
Feb 29
Senate Rules "X" file.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos